Patrizio Mattei is a distinguished scientist in Medicinal Chemistry at the Roche Innovation Center Basel, Pharma Research & Early Development (pRED). His research primarily focuses on metabolic diseases, ophthalmology, and more recently, antibiotics. Patrizio is a co-inventor of zosurabalpin, a first-in-class antibiotic currently progressing to phase 3 clinical trials.
Before joining Roche in 1999, Patrizio earned a Doctor of Sciences degree from ETH Zürich and was a postdoctoral research fellow at The Scripps Research Institute in La Jolla, California.